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Introduction
Trypanosoma brucei is an extracellular protozoan parasite re-
sponsible for a reemerging tropical disease known as sleeping 
sickness in humans. There are two main proliferative forms of 
the parasite: the bloodstream form in the mammalian host and 
the midgut insect stage or procyclic form in the tsetse vector. 
Changes in the variant surface glycoprotein (VSG) type on the 
surface allow the bloodstream form of the parasite to elude the 
host immune antibody response, ensuring a persistent infection 
(Cross et al., 1998; Barry and McCulloch, 2001; Pays et al., 
2004). The monoallelically expressed VSG gene is always lo-
cated at the end of a telomeric VSG expression site (ES). Previ-
ous estimations suggest the presence of 20 different telomeric 
VSG ESs that share highly homologous promoter sequences. 
The VSG ES promoter, which is located 40–60 kb upstream 
of the telomere, drives the polycistronic transcription of devel-
opmentally regulated genes named ES-associated genes (for 
 review see Pays et al., 2004). In the bloodstream form, only one 
VSG ES is fully transcribed at a given time so that each cell dis-
plays a single VSG type on the surface. Transcriptional switch-
ing among ESs results in antigenic variation. In the procyclic 
form, VSG is not expressed, but an invariant family of glyco-
proteins called procyclins are constitutively expressed and 
 replace VSG on the parasite surface (Roditi et al., 1989). Previ-
ous data suggest two distinct mechanisms for ES regulation: 
a developmental silencing of the ES in the procyclic form and 
a coupled mechanism for ES activation/inactivation in the 
bloodstream form (Navarro et al., 1999).
In eukaryotic cells, RNA polymerase I (pol I) transcribes 
ribosomal loci (ribosomal DNA [rDNA]) and is highly com-
partmentalized in the nucleolus (for review see Scheer and 
Hock, 1999). Interestingly, in T. brucei, pol I also transcribes 
procyclin and VSG. Previously, we have proposed a model 
whereby the recruitment of a single VSG ES to a discrete pol 
I–containing extranucleolar body (ES body [ESB]) defi nes the 
mechanism responsible for VSG monoallelic expression (Navarro 
and Gull, 2001; for review see Borst, 2002).
In this study, we investigate the nuclear localization of 
pol I–transcribed chromosomal sites in the context of pol I machin-
ery and transcription activity. Our results show that the nonmu-
tually exclusive procyclin gene family is transcribed at the 
nucleolus periphery in contrast to the monoallelically expressed 
VSG ES, which is associated with the extranucleolar ESB. 
 Furthermore, we address the possible repositioning of blood-
stream pol I–transcribed loci during differentiation to the insect 
procyclic form. We found that upon developmental silencing, 
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the active VSG ES promoter is subjected to nuclear envelope 
 repositioning concomitant with ESB disassembling and is 
 followed by chromatin condensation.
Results and discussion
Nuclear positioning dynamics of developmentally regulated 
chromatin domains is involved in coordinating transcriptional 
activation and repression. For a precise positional analysis of 
a particular sequence in nuclei, we have adapted the in vivo GFP 
tagging of chromosomes (Robinett et al., 1996) to bloodstream 
and procyclic trypanosomes. By expressing GFP-LacI in a 
 tetracycline-inducible system (Wirtz et al., 1999), we are able to 
localize a particular DNA sequence in the nucleus, as visualized 
by GFP-LacI binding to lac operator sequences inserted in a 
chromosome site in vivo and in fi xed cells, thereby exploiting 
the advantages of this tool (for review see Gasser, 2002). 
T. brucei immunofl uorescence (IF) analysis has been consider-
ably improved by adapting 3D deconvolution wide-fi eld fl uo-
rescence microscopy (Engstler and Boshart, 2004) to the study 
of nuclear architecture in this paper.
Researchers have reported that heterologous genes tran-
scribed from the procyclin locus generate mRNAs that are 
 localized either to the nucleolus (Rudenko et al., 1991; Chung 
et al., 1992) or to the nucleoplasm (Chaves et al., 1998), as 
 assessed by RNA-FISH. However, the nuclear position of the 
procyclin chromosomal loci has not been investigated. In this 
study, we address the nuclear position of the procyclin chromo-
somal locus, which is transcribed by pol I (Rudenko et al., 1990) 
and is developmentally regulated (Roditi et al., 1989). For this 
purpose, the lac operator repeats were chromosomally inserted 
 upstream of a procyclin promoter within the procyclin (GPEET-
PAG3) locus. First, to avoid possible fi xing artifacts, the posi-
tion of the procyclin locus was determined in vivo. After DAPI 
staining of DNA in the nucleus of live cells, the position of the 
nucleolus was indirectly determined by the absence of DAPI 
staining, and localization of the GFP-LacI bound to the procy-
clin locus was visualized upon GFP-LacI induction. A fl uo-
rescent GFP dot was clearly visible upon induction, and its 
localization was determined to be at the periphery of the nucleo-
lus (Fig. 1 a). Live cell 3D microscopy confi rmed that the pro-
cyclin locus was confi ned to the border of the nucleolus (Video 1, 
available at http://www.jcb.org/cgi/content/full/jcb.200607174/
DC1). Second, to more precisely determine the position of this 
sequence in the nucleus with respect to the nucleolus, we per-
formed IF analysis in PFA-fi xed cells. The localization of GFP-
LacI was detected using an anti-GFP monoclonal antibody, and 
pol I was stained using affi nity-purifi ed anti–pol I large subunit 
(anti-TbRPA1) antiserum (Navarro and Gull, 2001). Analysis of 
deconvolved 3D datasets indicated that the GFP-LacI–tagged 
procyclin locus is associated with the nucleolus (Fig. 1 b).
Interestingly, this position was observed in 97.8% of GFP 
dot–positive cells (Table I), suggesting a highly constrained chro-
mosomal position, which was confi rmed by time-lapse fl uores-
cence imaging in living cells (Video 2, available at http://www.
jcb.org/cgi/content/full/jcb.200607174/DC1). Because the pro-
cyclin gene family is transcribed at a similar level for all allelic 
variants (Acosta-Serrano et al., 1999), there seems to be no need 
to associate them with a single extranucleolar body, which is 
Figure 1. GFP-LacI tagging of the procyclin locus in the nucleus of the 
T. brucei procyclic form. (a) In vivo ﬂ uorescence detection of the GFP-LacI 
bound to lac operator sequences (green) inserted into the procyclin locus. 
DNA was stained with DAPI (blue), and the cell was visualized by phase 
contrast (gray). A single optical section from a deconvolved two-channel 3D 
dataset is shown using a 0.5-μm z step (slice animation available as Video 1, 
available at http://www.jcb.org/cgi/content/full/jcb.200607174/DC1). 
(a′) Higher magniﬁ cation of the nucleus showing GFP-LacI and DAPI ﬂ uores-
cence signals. (b) 3D IF analysis of a procyclic-form interphase nucleus re-
vealing localization of the GFP-LacI–tagged procyclin chromosomal locus 
using an anti-GFP monoclonal antibody (green) and localization of pol I 
 using a polyclonal antibody against pol I (TbRPA1; red). DAPI staining (blue) 
reveals the nucleus as well as the mitochondrial DNA and indirectly indicates 
the position of the nucleolus because of its lack of DAPI staining. Pol I is ex-
clusively localized in the nucleolus and displays a characteristic U-shape 
structure. The procyclin locus is detected in the nucleolar periphery in living 
and ﬁ xed cells. Maximum intensity projection of a three-channel 3D stack (b) 
or maximum anti-GFP intensity slice (b′) are shown. Dotted line indicates the 
nuclear  outline. Bars, 1 μm.
Table I. Nuclear positional analysis by 3D IF in procyclic-form 
GFP-tagged cell lines
GFP-tagged loci Detectable 
GFP dot
Perinucleolar Nuclear periphery
% % %
Procyclin promoter 
 (n = 102)
88.2 78.9 (18.9) 2.2
rDNA promoter 
 (n = 100)
88a 81.8 (17.1)a 1.1a
ES promoter 
 (n = 103)
63.1b 30.8 (27.7)b 41.5b
Different GFP-tagged cell lines were analyzed by 3D double IF with DAPI stain-
ing, anti-GFP, and anti–pol I antibodies. Interphase GFP-LacI–expressing cells 
were scored as GFP dot positive or negative (second column). Perinucleolar po-
sition as deﬁ ned by pol I labeling and DAPI staining is shown in the third column. 
Nuclear periphery position as determined by DAPI staining is shown in the fourth 
column. Cells matching both categories (nucleolar periphery signal in the nu-
clear periphery) are shown in parentheses in the third column (see Materials and 
methods for further details). Normalized percentages against GFP dot– positive 
cells are presented in the third and fourth columns. Statistical signiﬁ cance was 
calculated with a chi-square test against the procyclin promoter GFP-tagged 
cell line. Procyclin and rDNA promoters are located at the nucleolar  periphery, 
whereas the ES promoter is signiﬁ cantly located at the nuclear periphery 
(P < 0.001). The ES promoter–tagged cell line showed a reduced percentage 
of GFP dot–positive cells.
aNo signiﬁ cant difference.
bSigniﬁ cant difference (P < 0.001).
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in contrast to the model of the monoallelic expression of VSG ES 
in the bloodstream form (Navarro and Gull, 2001). Although in 
vitro differentiation from the bloodstream to the procyclic form 
is effi cient in T. brucei, the converse is not feasible. Thus, we are 
unable to address possible nuclear localization changes for the 
procyclin locus in the procyclic form (Fig. 1) upon differentiation 
to the bloodstream stage. The same lac operator construct that 
was used to tag the procyclin locus in procyclics was repeatedly 
used in bloodstream parasites with no success, suggesting that 
the procyclin promoter is developmentally down-regulated in the 
bloodstream form by a chromatin-mediated mechanism, as sug-
gested previously (Hotz et al., 1998).
IF analysis showed that pol I was exclusively localized 
to the nucleolus, and no substantial extranucleolar signal was 
detected (Fig. 1 b), ruling out the possibility of a specifi c pol 
I–containing body responsible for procyclin expression (Pays 
et al., 2004). Interestingly, pol I was found to be subcompart-
mentalized in the nucleolus, with distinct foci peripherally 
 distributed in a U-shaped pattern that was easily detectable by 
3D microscopy (Fig. 1 b). To investigate this unexpected pol I 
distribution, we performed BrUTP labeling of nascent RNA 
in situ (Navarro and Gull, 2001) in PFA-fi xed procyclic cells to 
determine the sites of pol I transcription. To exclusively detect 
pol I transcriptional activity in the nucleus of permeabilized 
cells, experiments were performed in the presence of high 
 concentrations of α-amanitin (100 μg/ml), which is known to 
 inhibit pol II and III transcription. Indeed, although many tran-
scriptional foci were distributed along the nucleus in the absence 
of the drug (Fig. 2 a), in the presence of α-amanitin, nascent 
RNA was solely detected in the nucleolus (Fig. 2 b). Further-
more, within the nucleolus, BrUTP-labeled RNA was confi ned to 
distinct foci located predominantly in a peripheral position simi-
lar to that of the GFP-LacI–tagged procyclin locus (Fig. 1 a).
To further investigate pol I–dependent transcriptional ac-
tivity, we determined the position of the rDNA in the procyclic 
form. Several independent clones were analyzed, and all re-
vealed a perinucleolar position for the GFP-LacI–tagged rDNA 
chromosomal site (Fig. 3 a and Video 3, available at http://www.
jcb.org/cgi/content/full/jcb.200607174/DC1). Again, the posi-
tion of the GFP-LacI bound to the rDNA locus associated with 
the position of pol I and showed a stable perinucleolar position 
(98.9% of GFP dot–positive cells) when examined by 3D 
 microscopy (Table I). The peripheral nucleolus location of 
 procyclin and rDNA loci, together with pol I transcription foci 
along the nucleolus periphery (Fig. 2) instead of an inner cen-
tral position, may explain the lack of colocalization of these 
two loci that were described previously using RNA-FISH 
(Chaves et al., 1998).
To determine whether the peripheral distribution of pol 
I–transcribed loci in the nucleolus is a unique feature of the 
insect form of the parasite or is also present in the bloodstream 
form, we addressed the position of the rDNA locus. We 
 performed 3D IF of bloodstream-form cells upon PFA fi xation 
Figure 2. BrUTP labeling of nascent RNA in permeabilized procyclic-form 
nuclei. Double IF using anti–pol I antiserum (red) and a monoclonal anti-
body against BrdUTP (green) together with DNA staining using DAPI (blue) 
in PFA-ﬁ xed cells. (a) Total nuclear transcription in situ as revealed by the 
incorporation of BrUTP into nascent RNA in the absence of α-amanitin. 
(b) BrUTP-labeled nascent RNA transcribed by pol I in the presence of 
100 μg/ml α-amanitin. Pol I–mediated transcription is conﬁ ned to several 
perinucleolar foci (green), indicating that pol I transcription occurs largely 
along the periphery of the nucleolus. Single deconvolved slices are shown. 
Bars, 1 μm.
Figure 3. Localization of a GFP-LacI–tagged rDNA chromosomal site in the procyclic and bloodstream forms of T. brucei. (a) Localization of the rDNA locus 
tagged with lac operators in the procyclic form visualized by an anti-GFP monoclonal antibody (green) and anti–pol I antiserum (red) in the nucleolus 
 (arrow). (b) As in panel a, but using bloodstream-form parasites. Anti-pol antibody (red) stained the nucleolus (arrow) and the extranucleolar pol I–containing 
body, the ESB (arrowhead). In both developmental stages, the rDNA chromosomal sites are located in the nucleolar periphery. (c) The ESB (arrow) is associ-
ated with the GFP-tagged active VSG ES promoter, which was detected by double labeling using anti–pol I (red) and anti-GFP (green) antibodies in the PFA-
ﬁ xed bloodstream form. Note the U-shape distribution of pol I in the nucleolus (arrowhead). Maximum intensity projections of 3D stacks (a–c) or maximum 
anti-GFP intensity slices (a′–c′) are shown. Dotted lines indicate the nuclear outline. Bars, 1 μm.
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in suspension (Engstler and Boshart, 2004), which preserves 
nuclear structure better than the previously used fi xation condi-
tions (Navarro and Gull, 2001). The position of rDNA locus in 
the bloodstream form localized to the nucleolus and, similar to 
the procyclic form, was peripheral with an equivalent con-
strained position (98% of GFP dot–positive cells; Fig. 3 b).
To investigate a possible nuclear position–dependent reg-
ulation of pol I–transcribed chromosomal sites in the blood-
stream developmental form, we fi rst analyzed the position of 
the active VSG ES promoter. Double IF using an anti–pol I anti-
body and an anti-GFP antibody showed that the active VSG ES 
tagged with GFP-LacI localizes to the ESB as previously de-
scribed (Navarro and Gull, 2001), whereas pol I was present in 
the ESB as well as in the nucleolus (Fig. 3 c). We also addressed 
the nuclear position of the internal chromosomal VSG basic 
copy (BC) tandem genes. These copies of different VSG genes 
serve as substrates for recombination events into the active 
ES telomere, resulting in an antigenic switch. The GFP-LacI–
tagged VSG121 BC locus showed no association with the ESB, 
which is similar to an inactive 121 ES promoter region (Navarro 
and Gull, 2001). Importantly, statistical IF position analysis of 
both the BC and inactive ES promoter sequences revealed no 
considerable association to the nuclear envelope (2% of GFP 
dot–positive cells). We show that in bloodstream form, the telo-
meric silencing of VSG ES proposed previously (Horn and 
Cross, 1995) is not associated to either nuclear periphery repo-
sitioning or chromatin condensation.
We next determined whether the active VSG ES undergoes 
nuclear repositioning upon developmental differentiation from 
the bloodstream to the procyclic form, where no VSGs are 
 expressed. For this purpose, the differentiation of bloodstream- to 
procyclic-form parasites was induced in vitro, and nuclear locali-
zation changes were analyzed early (5 h) or late (24 h) during 
differentiation. To assess the differentiation process, we moni-
tored the developmental expression of the surface glycoprotein 
procyclin by double IF using anti–EP procyclin and anti-
VSG221 antibodies. 22% of the cells displayed procyclin on the 
surface 5 h upon in vitro differentiation. This value increased 
24 h upon differentiation, with 83% of cells exclusively displaying 
procyclin on the cell surface and 5% displaying a mixed coat of 
procyclin and VSG. The remaining 10% of cells that solely dis-
played VSG on the surface can be interpreted as differentiation 
retarded or defective in the asynchronous differentiation process 
that occurs in this monomorphic cell line. 3D IF analysis showed 
that the active VSG ES promoter relocated to the nuclear enve-
lope early during differentiation (5 h; Fig. 4 a). Importantly, at 
the same time, extranucleolar pol I (ESB) was no longer 
detected, which is consistent with our observation that pol I ex-
clusively localizes to the nucleolus in the established procyclic 
form (Fig. 1). Statistical analysis of the position indicated that 
70% of the nuclei display the GFP-LacI dot at the nuclear pe-
riphery 5 h upon differentiation (Fig. 4 c). The relocation of the 
active ES promoter to the nuclear periphery in 70% of the cells 
was higher than the number of procyclin-positive cells (22%), 
suggesting that VSG ES nuclear reposition silencing is preced-
ing the full surface expression of procyclin. Finally, 24 h upon 
in vitro differentiation, the GFP-tagged active VSG ES promoter 
was located to the nuclear periphery in 88% of the cells (Fig. 4 c) 
displaying procyclin on their surface.
To determine whether such rapid developmental reposi-
tioning was a unique feature of the active ES promoter, we 
 determined the localization of various other chromosomal 
 sequences. For example, the rDNA locus showed no change in 
nuclear localization either 5 (Fig. 4 b) or 24 h upon differen-
tiation and was always detected in a perinucleolar location 
(100% of GFP dot–positive cells; Fig. 4 c). Similarly, statistical 
analysis on the location of the GFP-LacI–tagged VSG121 
BC and inactive VSG ES promoter chromosome sites showed 
no signi fi cant nuclear envelope repositioning upon early differ-
entiation (Fig. 4 c).
Figure 4. Changes in nuclear localization and chromatin accessibility of 
the active ES promoter upon in vitro differentiation. (a) The GFP-tagged ac-
tive ES promoter (green) localized to the nuclear periphery upon differenti-
ation, as indicated by double labeling with an anti-GFP monoclonal 
antibody (green), anti–pol I antiserum (red), and DAPI staining (blue). 5 h 
after the induction of differentiation, the extranucleolar ESB is not detect-
able, and the GFP-tagged active VSG ES is now located at the nuclear en-
velope (as determined by the edge of DAPI staining). (b) In contrast, the 
GFP-LacI–tagged rDNA chromosomal site does not show nuclear reposi-
tioning. Maximum intensity projections of three-channel 3D datasets (a and b) 
or maximum anti-GFP intensity slices (a′ and b′) are shown. Dotted lines 
indicate the nuclear outline. Bars, 1 μm. (c) Statistical analysis on the num-
ber of GFP dot–positive cells where the GFP-LacI dot is in contact with the 
nuclear periphery in cells tagged in the rDNA, 121VSG BC, inactive ES, 
or active ES promoter loci. BSF, bloodstream form. (d) Statistical analysis of 
the number of GFP-expressing cells in which a clear GFP-LacI dot is visible 
in cells tagged in the rDNA, 121VSG BC, inactive ES, or active ES pro-
moter regions. The profound lack of detection of the GFP-LacI bound to 
chromatin in the active ES promoter suggests a reduced chromosomal ac-
cessibility of this locus upon differentiation.
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Together, our data indicate that the active VSG ES pro-
moter sequences reposition to the nuclear periphery concomi-
tantly with the ES transcription silencing during differentiation 
to the insect form (Navarro et al., 1999). Importantly, rapid nu-
clear repositioning of the VSG promoter detected at 5 h after 
differentiation induction precedes the full down-regulation of 
VSG transcription given that VSG mRNA is still clearly detect-
able at 12 h after differentiation (Janzen et al., 2006). This is 
the case despite that VSG mRNAs are down-regulated by the 
3′- untranslated region in the procyclic form (Berberof et al., 1995). 
This mechanism seems to be specifi c for the active ES promoter, 
as such rapid repositioning was not observed for the inactive 
121 ES promoter or VSG121 BC loci at early differentiation 
stages (Fig. 4 c).
Interestingly, although 83% of GFP-positive nuclei tagged 
at the active VSG ES promoter showed a clear GFP-LacI dot in 
an exponentially growing bloodstream culture, upon 24 h of dif-
ferentiation and nuclear repositioning, only 8% of the GFP-
positive nuclei showed a detectable GFP-LacI dot (Fig. 4 d). In 
contrast, detection of the GFP-LacI bound to rDNA was evident 
in 98% of the GFP-positive nuclei even 24 h upon  differentiation. 
Cell lines tagged either at the inactive 121 ES promoter region 
or in the VSG121 BC region showed an intermediate situation, 
with 53–76% of the cells displaying a visible GFP dot 24 h 
upon differentiation (Fig. 4 d). Similar data were also obtained 
by in vivo GFP fl uorescence direct visualization. In late differ-
entiation (24 h), cells showed a GFP-LacI dot for the rDNA 
 locus that was easily detectable. In contrast, 24 h upon differen-
tiation, when the active ES was tagged, the GFP-LacI dot was 
almost undetectable even though the cells displayed diffuse 
GFP expression in their nuclei (Fig. 4 d).
These differential results suggest that GFP-LacI binding 
to the lac operator sequences inserted into distinct chromosomal 
positions refl ect differences in chromatin accessibility and, thus, 
allow us to detect changes in chromatin condensation. These 
data are supported by the previously described VSG ES chromatin 
remodeling of the bloodstream VSG ES after differentiation 
to the procyclic form to yield a structure that is no longer per-
missive for T7RNAP transcription in vivo (Navarro et al., 1999; 
Janzen et al., 2004). Recently, Dietzel et al. (2004) detected an 
opposing chromatin decondensation event upon gene activation 
utilizing the accessibility of GFP-LacI. In this context, changes 
in chromatin seem to dramatically affect the accessibility of 
GFP-LacI to the lac operators inserted in the active VSG ES 
promoter region, as indicated by the drastic decrease in the 
number of nuclei with a detectable GFP dot (Fig. 4 d). Although 
chromatin in the rDNA locus is not affected at all upon differen-
tiation, a moderate degree of chromatin condensation was also 
found for the VSG121 BC and inactive 121 ES promoter regions 
even though these loci are not transcribed in the bloodstream 
form. Moreover, an eventual repositioning of inactive ES pro-
moter to the nuclear envelope does occur, as tagging the inac-
tive ES promoter regions in established procyclic form revealed 
that these chromosomal loci localized to the nuclear envelope in 
41.5% of nuclei (Table I). The active VSG ES promoter reposi-
tioning in 88% of cells at early stages of the differentiation pro-
cess is in contrast with the 41.5% of nuclei detected for the 
promoter locus in established procyclics (Fig. 4 c and Table I). 
Thus, our results show that nuclear repositioning targets more 
effi ciently at early stages during the differentiation process and 
suggest that the establishment of silencing requires a transient 
perinuclear localization.
Despite many correlations between nuclear localization and 
gene activity, it remains unclear whether nuclear repositioning 
is the cause or the result of such activity. Like yeast (Gartenberg 
et al., 2004), TbKU80-defi cient trypanosomes are unable to 
halt VSG ES developmental silencing (Janzen et al., 2004) or 
the silencing of all VSG ESs but one in the bloodstream form 
(Conway et al., 2002), but no information on possible nuclear 
repositioning is available for this mutant. Although we cannot 
conclude that nuclear repositioning causes silencing, impor-
tantly, our data provide new insights into this problem. First, 
the active VSG ES promoter, located 60 kb upstream of the telo-
mere, is the sole target for nuclear envelope relocation during 
differentiation, which is in contrast to inactive VSG ES promot-
ers. Second, this rapid repositioning precedes chromatin con-
densation during differentiation (Fig. 4, c and d).
Nuclear envelope repositioning and chromatin condensa-
tion events have been suggested to affect pol II promoter activi-
ties in yeast and mammalian cells (Spector, 2003). Our data 
represent the fi rst example of a pol I–transcribed chromatin 
 domain targeted by a nuclear position–dependent silencing 
mechanism, indicating that such regulation is not restricted to 
pol II and that nuclear architecture plays a universal role in the 
 epigenetic regulation of transcription.
Materials and methods
Trypanosomes and 3D IF
T. brucei bloodstream-form (Molteno Institute Trypanozoon antigenic type 
1.2 [MITat 1.2]; clone 221a) and 427 procyclic-form DNA transfections 
and selection procedures were described previously (Wirtz et al., 1999). 
For these studies, the bloodstream cell lines were differentiated in vitro to 
procyclics using standard conditions but with SDM-79 medium (Overath 
et al., 1986). IF was performed on cells in suspension (Engstler and 
Boshart, 2004) except that ﬁ xation was performed for 2.5 h on ice with 
4% PFA and permeabilized with 1% NP-40 for 1 h at room temperature. IF 
was performed in 1% blocking reagent (Roche) in PBS (Sigma-Aldrich) 
 using the monoclonal anti-GFP (Invitrogen) and afﬁ nity-puriﬁ ed anti–pol I 
(TbRPA1) rabbit antiserum (1:600; Navarro and Gull, 2001). Alexa-
Fluor488- or -594–conjugated goat species–speciﬁ c antibodies (Invitro-
gen) were used as secondary antibodies, and cells were DAPI stained and 
mounted as described previously (Engstler and Boshart, 2004). Stacks 
(0.1-μm z step) acquisition was performed with a microscope system (Cell 
R IX81; Olympus), 63×/100× objectives, illumination system (MT20; 
Olympus), and camera (Orca CCD; Hamamatsu). Deconvolution of 3D 
 images was performed using Huygens Essential software (version 2.9; 
 Scientiﬁ c Volume Imaging) using an experimentally calculated point-spread 
function with 0.2-μm TetraSpeck microspheres (Invitrogen). All images dis-
played in the ﬁ gures are maximum intensity projections from digitally de-
convolved multichannel 3D image datasets. Pseudocoloring and maximum 
intensity projections were performed using ImageJ software (version 1.37; 
National Institutes of Health). Nascent RNA labeling in permeabilized pro-
cyclic form was essentially performed as described previously for the 
bloodstream form (Navarro and Gull, 2001) except that cells were ﬁ xed 
with 2% PFA for 20 min. The single-slice deconvolution shown in Fig. 2 was 
performed using Huygens software with 0.3 μm as a z sample size.
GFP-Lac repressor tagging of chromosome sites
We have adapted the in vivo GFP tagging of chromosomes (Robinett et al., 
1996; Straight et al., 1996) to bloodstream and procyclic trypanosomes. 
GFP-LacI was expressed in a tetracycline-inducible manner (Wirtz et al., 
1999). We localized a particular DNA sequence in the nucleus by 
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 detection of the GFP-LacI bound to the lac operator sequences inserted in 
a chromosome. Stable transformants in T. brucei occur by homologous 
 recombination, allowing us to insert a lac operator tagging cassette by a 
single crossover.
The bloodstream single marker (SM) cell line (Wirtz et al., 1999) 
and the procyclic cell line 1313-1333 (Alibu et al., 2005) were used 
for tetracycline-inducible expression. To express the GFP-LacI fusion in a 
tetracycline-dependent manner, we used pMig75, which was described 
previously (Navarro and Gull, 2001), in procyclic (1313-75) and blood-
stream forms (SM-75). These two cell lines were used to obtain all transfor-
mants with the lac operator tagging constructs (described in the next 
paragraph) in the absence of tetracycline induction.
To GFP-LacI tag any locus of interest, we developed a series of con-
structs containing variable target DNA upstream of a 256–lac operator–
containing fragment (Navarro and Gull, 2001) and downstream of the 
promoter of the locus under study, which will drive expression of the select-
able marker. To GFP tag the procyclin (GPEET/PAG3) locus, the targeting 
sequence located 60 bp upstream of the endogenous procyclin promoter 
was a PCR fragment generated using oligonucleotides (5′-CGAGCTCAT A-
C C G C T G C C G G C C T A A A T G C -3′ and 5′-CAAGCTTCA T T T T G C A C A A A A T-
G C A C T A T T G -3′). To drive the expression of the hygromycin selectable 
marker, we used a procyclin promoter obtained by PCR using oligonucle-
otides (5′-G T G G A T C C T C C A T T T T G T G G C A G T G A T G G -3′ and 5′-C G C C A T-
G G A A A G G G A A C G A G G T G C C A T T G -3′). To tag the rDNA spacer located 
between two rDNA repeats, the targeting sequence was a PCR fragment 
(5′-A A T T C G A G C T C A T A T A G T T G G -3′ and 5′-C G C G A A G C T T C G G T G T G T-
T G C C A A A G A C A T T C -3′) using pLew82 as a template (Wirtz et al., 1999). 
To drive a bleomycin selectable marker, we used a ribosomal promoter ob-
tained by PCR using oligonucleotides (5′-C G A G G G A T C C A C C C A G C G C-
G G G T G C A T T C -3′ and 5′-G G C A T A T G C A G T C C T G C T C C T C G G C C -3′). 
The 121VSG BC target sequences that we used were the full 121VSG 
cDNA and the ES promoter described previously (Navarro et al., 1999). 
The constructs to tag the active 221 ES and the inactive 121 ES were previ-
ously described (Navarro and Gull, 2001). All constructs were inserted 
upstream of the promoter of the locus under study, resulting in tandem re-
peats of similar promoters. However, in the case of the 121VSG BC target-
ing construct, we included an ES promoter to drive the selectable marker 
that is not present in the endogenous locus. GFP-LacI expression was 
induced in early exponential cultures with 1–0.1 μg/ml doxycycline 
(Sigma-Aldrich) for bloodstream and procyclics, for 16 h. Simultaneously 
with differentiation induction, the expression of GFP-LacI was induced with 
0.1 μg/ml doxycycline.
Statistical position analysis
GFP-LacI expression in SM-75 and 1313-75 cell lines displayed a propor-
tion of nuclei that did not express the GFP-LacI fusion after induction even 
without the lac operator repeats. Thus, this variable expression was not 
caused by a toxic effect but rather by variegated activity of the procyclin 
promoter driving the expression of GFP-LacI. Thus, all statistical analyses in 
both developmental stages described in this paper are based on GFP-
LacI–positive nuclei cells recognized by the unbound GFP-LacI that was de-
tected in a dispersed manner in the nucleoplasm. Statistical analysis of 
GFP-LacI–expressing nuclei that were positive or negative for the GFP dot 
was performed in 100–120 interphase nuclei. The positive ones were 
grouped in different categories based on the GFP dot nuclear position 
within the DAPI staining (nuclear periphery, nucleolus, and nucleoplasma) 
and the relative position between the GFP dot and pol I signals. The scor-
ing was performed by direct optical observation. Questionable cells were 
analyzed by 2D or 3D digital imaging. At least 20 representative cells 
were analyzed by 3D deconvolution microscopy. Tagged chromosome 
 position and GFP dot detection probability distributions were compared 
between categories indicated with an asterisk in Fig. 4 using chi-square 
analysis. Statistical signiﬁ cance was determined by using a 95% conﬁ -
dence interval.
Online supplemental material
Video 1 shows a T. brucei live cell in which the procyclin chromo-
somal site is tagged with GFP-LacI. Video 2 shows in vivo visualization of 
the highly transcribed procyclin chromosomal site tagged with GFP in a 
procyclic-form trypanosome. Video 3 shows 3D deconvolved slice anima-
tion through the whole ﬁ xed nucleus. Online supplemental material is avail-
able at http://www.jcb.org/cgi/content/full/jcb.200607174/DC1.
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